Moderna has recruited its first participants in the first phase of clinical trial testing MRNA-1273, its vaccine is against the novel coronavirus that causes COVID-19. The move brings biotech one step closer to possibly the first COVID-19 vaccine available in the United States, although this time is not surprising. Moderna announced plans to begin mid-term